MD Anderson Cancer Center/University of Texas MD Anderson CC — Houston, Texas

MD Anderson Cancer Center/University of Texas MD Anderson CC is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Clinical Trials Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

MD Anderson Cancer Center/University of Texas MD Anderson CC has participated in 2 clinical trials.

Therapeutic areas: Relapsed and Bortezomib Refractory Multiple Myeloma, Refractory Multiple Myeloma, Multiple Myeloma in Relapse.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Houston

Browse all research sites in Texas · View every site in Houston

• The University of Texas MD Anderson Cancer Center /ID# 277929
• UT Health/ Memorial Hermann Hospital
• University of Texas Vanguard Urologic Research Foundation
• Anxiety and Health Research Lab, Substance Use Treatment Clinic, University of Houston
• Texas Children's Hospital West Campus
• The Methodist Hospital Houston
• The University Of Texas at Houston
• Houston Methodist Hospital - 6565 Fannin St
• Ben Taub General Hospital / Baylor College of Medicine/Harris Health System
• Lyndon B. Johnson Hospital (Site 1014), 5656 Kelley Street
• The Methodist Hospital Research Institute; Academic Office of Clinical Trials
• University of Texas Health Sciences Center at Houston - Center for Advanced Heart Failure

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson Cancer Center/University of Texas MD Anderson CC?

MD Anderson Cancer Center/University of Texas MD Anderson CC has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson Cancer Center/University of Texas MD Anderson CC conducted?

MD Anderson Cancer Center/University of Texas MD Anderson CC has 2 clinical trials on record. Their work covers Relapsed and Bortezomib Refractory Multiple Myeloma, Refractory Multiple Myeloma, Multiple Myeloma in Relapse.

Is MD Anderson Cancer Center/University of Texas MD Anderson CC accredited by Crixeo Clinical Trials?

MD Anderson Cancer Center/University of Texas MD Anderson CC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Anderson Cancer Center/University of Texas MD Anderson CC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.